Dr. Nima Alaeiilkhchi joined the TI in March 2024 as a postdoctoral fellow following the completion of his PhD in Neuroscience. His doctoral research was dedicated to exploring metabolic treatments for multiple sclerosis (MS) using murine models. This work reflects his passion for deepening his understanding of complex biological systems and his ambition to bridge the gap between laboratory research and clinical application as a future clinician-scientist. Moreover, with nearly a decade of experience working with the Cochrane Hypertension Group, Nima has developed a robust expertise in conducting systematic reviews.

Nima will collaborate with Dr. Wade Thompson and Dr. Anshula Ambasta, focusing on systematic reviews and evidence synthesis in the realm of deprescribing and the management of polypharmacy, particularly among older populations. His work under Dr. Thompson’s guidance involves employing a multi-methods approach to research, aiming to optimize medication use in alignment with patients’ healthcare goals and preferences. Concurrently, with Dr. Ambasta, he will contribute to qualitative research efforts targeted at enhancing healthcare quality and patient safety, with a keen interest in the reduction of low-value services. This collaborative work not only aligns with his passion for translating research into actionable clinical practices but also marks a significant step in his journey toward impactful translational research and clinician-scientist excellence.

Social Media / Lab or Research Website

Website (or Lab):

Research Theme(s)

Publication Link(s)